how long have glp 1 drugs been around History of GLP-1 Medications GLP-1 Drugs Market Size to
Description
The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
515,516,517 GLP-1 may improve the livers antioxidant capacity and metabolic function by activating Sirt1, thereby helping to alleviate the pathological changes associated with NASH
[6] Tirzepatide (Mounjaro): up to 15 mg once weekly for type 2 diabetes, and up to 15 mg once weekly for chronic weight management (marketed as Tirzepatide)
It has been shown that an increased percentage of fat, adipose tissue dysfunction, and IR lead to increased levels of FFAs and carbohydrates
Research is ongoing into their use for heart disease, fatty liver, and even inflammatory conditions
